Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2002
03/28/2002US20020037293 Chlamydia antigens and corresponding DNA fragments and uses thereof
03/28/2002US20020037290 Compositions comprising heat shock proteins or alpha(2) macroglobulin, antigenic molecules and saponins, and methods of use thereof
03/28/2002US20020037289 Combined methods and compositions for tumor vasculature targeting and tumor treatment
03/28/2002US20020037288 As therapeutic agents for T cell tumors or B cell tumors (excluding myeloma)
03/28/2002US20020037286 Methods for altering T cell and macrophage activation
03/28/2002US20020037284 Administering to an individual having the disorder an effective amount of secretin to improve a symptom of the disorder
03/28/2002US20020037281 Methods of transducing neural cells using lentivirus vectors
03/28/2002US20020037279 Delivery of bioactive compounds to an organism
03/28/2002US20020037278 Therapeutic angiogenesis by bone marrow-derived cell transplantation in myocardial ischemic tissue and skeletal muscle ischemic tissue
03/28/2002US20020037274 Single agent method for killing tumor and tumor associated endothelial cells using adenoviral mutants
03/28/2002US20020037273 Interferon-alpha mediated upregulation of aquaporin expression
03/28/2002US20020037260 Compositions for treating biofilm
03/28/2002US20020037259 Compositions for controlling bacterial colonization
03/28/2002US20020035998 Method for treatment of cancer and infectious disease
03/28/2002US20020035993 Highly efficient delivery of a large therapeutic mass aerosol
03/28/2002US20020035992 Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
03/28/2002DE10106829A1 Arzneimittel mit einer für das RNA-bindende KOC-Protein kodierenden DNA-Sequenz, einem KOC-Protein oder einer DNA-Sequenz des KOC-Promotors Drugs with a gene encoding the RNA binding protein KOC-DNA sequence, a protein or KOC a DNA sequence of the promoter KOC
03/28/2002DE10045935A1 New two-chain protein isolated from Bitis gabonica rhinoceros venom by cation exchange chromatography, useful as specific inhibitor of the intrinsic blood coagulation system
03/28/2002DE10045592A1 Ein Antikörper-TNF-TNF Inhibitor Fusionsprotein (TNF-Selektokin) als zielspezifisches Prozytokin zur Tumortherapie An antibody-TNF TNF inhibitor fusion protein (TNF-Selektokin) as target-specific Prozytokin for tumor therapy
03/28/2002DE10043457A1 Verfahren zur Behandlung von Schizophrenie und verwandten Psychosen sowie Verwendung von Erythropoietin oder Erythropoietinderivaten zur Behandlung von Schizophrenien und verwandten Psychosen A method for the treatment of schizophrenia and related psychoses, and the use of erythropoietin for the treatment or Erythropoietinderivaten of schizophrenia and related psychoses
03/28/2002DE10042609A1 Verwendung von T-Proteinen zur differentiellen Charakterisierung und Therapie von Verletzungen und Tumoren des Nervensystems The use of T-proteins for differential characterization, and therapy of injuries and tumors of the nervous system
03/28/2002DE10042447A1 Protein aus dem Darm von Wirbeltieren, welches Cholesterin absorbiert, sowie Verwendung dieses Proteins zur Identifizierung von Inhibitoren des intestinalen Cholesterintransports Protein from the intestines of vertebrates, which absorbs cholesterol, as well as use of this protein for the identification of inhibitors of intestinal cholesterol transport
03/28/2002DE10040858A1 Perfluoralkylhaltige Komplexe mit polaren Resten, Verfahren zu deren Herstellung und ihre Verwendung Perfluoroalkyl-containing complexes with polar radicals, process for their preparation and their use
03/28/2002DE10028376A1 Epididymis-spezifische Proteine mit Fibronektin Typ II-Modulen Epididymis-specific proteins with fibronectin type II modules
03/28/2002CA2632702A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/28/2002CA2460014A1 Spas-1 cancer antigen
03/28/2002CA2427490A1 Methods for improving the antagonistic/agonistic properties of peptidic antagonists/agonists of the corticotropin-releasing factor receptor (crfr)
03/28/2002CA2424394A1 Growth factor complex comprising an insulin-like growth factor binding protein bound to vitronectin
03/28/2002CA2423181A1 Isolated nucleic acid molecules which encode a soluble il-tif/il-22 receptor or binding protein which binds to il-tif/il-22, and uses thereof
03/28/2002CA2423108A1 .beta.-catenin nuclear localizing protein
03/28/2002CA2423093A1 Improved system for regulation of transgene expression
03/28/2002CA2423082A1 Expression vectors containing hybrid ubiquitin promoters
03/28/2002CA2423058A1 Polypeptide having phospholipase a2 activity
03/28/2002CA2422911A1 New inhibitors of iapp fibril formation and uses thereof
03/28/2002CA2422902A1 Modified factor viii
03/28/2002CA2422868A1 Control of nk cell function and survival by modulation of ship activity
03/28/2002CA2422631A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/28/2002CA2422625A1 Method for use of igf-binding protein for selective sensitization of target cells in vivo
03/28/2002CA2422549A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
03/28/2002CA2422527A1 Treatment of tinnitus
03/28/2002CA2422508A1 Atp-binding cassette protein
03/28/2002CA2422451A1 Haemophilus influenzae basb202 polypeptide, production, vaccine and diagnostic use
03/28/2002CA2422215A1 B7-like molecules and uses thereof
03/28/2002CA2421877A1 Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen
03/28/2002CA2421865A1 Olfactory and pheromones g-protein coupled receptors
03/28/2002CA2421576A1 Human polynucleotides and polypeptides encoded thereby
03/28/2002CA2421249A1 21 human secreted proteins
03/28/2002CA2421056A1 A polypeptide for use as a diagnostic marker for the presence of colon tumours
03/28/2002CA2420862A1 Protein phosphatases
03/28/2002CA2420192A1 21 human secreted proteins
03/28/2002CA2420160A1 Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions
03/28/2002CA2407465A1 Method of blocking free radical processes which result in mediated pathology without deleterious pro-oxidant side reactions
03/28/2002CA2357853A1 Use of growth hormone secretagogues in conjunction with physical exercise
03/27/2002EP1191099A1 Novel polypeptide and dna thereof
03/27/2002EP1191098A2 Pharmaceutical composition for treatment of duchenne muscular dystrophy
03/27/2002EP1191096A1 Novel protein and dna thereof
03/27/2002EP1191037A1 Means of stabilizing hemoglobins
03/27/2002EP1191036A2 Methods and compositions for diagnosing and treating disorders involving angiogenesis
03/27/2002EP1191035A2 Three members of the cytokin-receptor class II family
03/27/2002EP1190709A1 Treatment of tinnitus
03/27/2002EP1190708A1 Medical use of substances
03/27/2002EP1190251A2 Detection of ryanodine receptor antibodies
03/27/2002EP1190249A2 Compounds and methods to enhance raav transduction
03/27/2002EP1190099A1 Antisense modulation of pi3k p85 expression
03/27/2002EP1190094A1 Antisense modulation of beta catenin expression
03/27/2002EP1190089A2 Methods of treatment using lig 72a and variants thereof
03/27/2002EP1190084A1 Regulation system of expression using nuclear ppar receptors
03/27/2002EP1190083A2 Dna constructs based on the eif4a gene promoter
03/27/2002EP1190074A1 Recombinant anti-cd40 antibody and uses thereof
03/27/2002EP1190073A2 Control of gene expression
03/27/2002EP1190072A2 22012, a novel human carboxypeptidase
03/27/2002EP1190071A2 17867, a novel human aminopeptidase
03/27/2002EP1190065A2 Atp binding cassette transporter protein abc1 polypeptides
03/27/2002EP1190063A1 Nucleic and proteinic acids corresponding to human gene abc1
03/27/2002EP1190061A1 Streptavidin expressed gene fusions and methods of use thereof
03/27/2002EP1190059A1 Sgip peptides
03/27/2002EP1190057A1 Cloning and expression of a novel 5-ht4 receptor
03/27/2002EP1190056A1 Human cytokine receptor
03/27/2002EP1190055A2 Human endogenous retrovirus in breast cancer
03/27/2002EP1190054A1 Epithelial cell growth inhibitors
03/27/2002EP1190053A2 Mammalian calcium channels and related probes, cell lines and methods
03/27/2002EP1190052A1 16405 receptor, a g-protein coupled receptor
03/27/2002EP1190051A2 Human transport proteins
03/27/2002EP1190050A2 Human transcriptional regulator proteins
03/27/2002EP1190049A1 Spliceosome protein and its use
03/27/2002EP1190047A1 Antisense oligonucleotide modulating cyclin e gene expression and therapeutic uses thereof
03/27/2002EP1190043A1 Glycoprotein vi and uses thereof
03/27/2002EP1190040A1 Herpes simplex virus expressing foreign genes and method for treating cancers therewith
03/27/2002EP1189947A1 Anti-idiotypic antibodies of fibroblast growth factors and their use as medicines
03/27/2002EP1189942A1 Somatostatin agonists
03/27/2002EP1189941A1 Neuromedin b and somatostatin receptor agonists
03/27/2002EP1189939A1 Bh3 modified peptides
03/27/2002EP1189936A2 Use of eif4e binding agents in therapy
03/27/2002EP1189933A1 Echinocandin derivatives, method for preparing same and application as antifungal agents
03/27/2002EP1189932A1 Novel echinocandin derivatives, method for preparing same and use as antifungal agents
03/27/2002EP1189931A2 Peptide compounds that bind her2
03/27/2002EP1189930A1 INHIBITORS OF THE INTEGRIN AlPHA V BETA 6
03/27/2002EP1189929A2 Factor viia inhibitors
03/27/2002EP1189926A2 Rapid dehydration of proteins
03/27/2002EP1189918A1 Antisense modulation of integrin beta 3 expression
1 ... 2096 2097 2098 2099 2100 2101 2102 2103 2104 2105 2106 2107 2108 2109 2110 2111 2112 2113 2114 2115 2116 ... 3163